Assessment of Uterine Access, Uterine Patency and Intrauterine Adhesions Following Endometrial Ablation

Inclusion Criteria: * Premenopausal female patients ≥ 18 years of age * Patient has undergone endometrial ablation within the prior 14 months. * There were no contraindications for endometrial ablation as specified in Ablation System labeling * Patient agrees to undergo an SLH either at 3, 6 or 12 months post-ablation * Patient abstained from any form of hormonal contraception including an IUD after the ablation and through the period that the SLH is performed. * Patient has signed the IRB approved informed consent. Exclusion Criteria: * Additional intrauterine procedures performed between time of endometrial ablation and the SLH; e.g., endometrial and/or myometrial resection. * IUD in situ * Pregnant (positive urine pregnancy test) or lactating * Active sexually transmitted infection or genital infection, or other clinically significant active and/or systemic infection per clinical or laboratory examinations at the time of endometrial ablation procedure or second look hysteroscopy (e.g., cervicitis, vaginitis, endometritis, or salpingitis). * Systemic steroid within 1 week of endometrial ablation * Previous adhesiolysis procedure or diagnosis of Asherman's disease. * No noted clinically significant uterine anomalies at the time of the ablation (e.g., septate uterus or other anomalies that distorts the uterine cavity) * Any other condition that in the opinion of the investigator could represent an increased risk for the subject, affect the primary outcomes of this study and/or impact the subject's ability to comply with protocol requirements. * Participating or considering participation in a clinical trial of another investigational drug or device during this study